93 related articles for article (PubMed ID: 8840341)
1. Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different hyperprolactinemic potency.
Rampello L; Raffaele R; Nicoletti G; Le Pira F; Malaguarnera M; Drago F
Neuropsychobiology; 1996; 33(4):186-8. PubMed ID: 8840341
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
3. Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.
Brambilla F; Penati G; Freni S; Bottinelli S; Maffei C; Maiella V
J Endocrinol Invest; 1979; 2(3):299-302. PubMed ID: 43342
[TBL] [Abstract][Full Text] [Related]
4. [Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
Liu KL; Lung FW
Kaohsiung J Med Sci; 1996 Dec; 12(12):685-90. PubMed ID: 9011126
[TBL] [Abstract][Full Text] [Related]
5. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
[No Abstract] [Full Text] [Related]
6. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
Mielke DH; Gallant DM; Kessler C
Am J Psychiatry; 1977 Dec; 134(12):1371-5. PubMed ID: 21571
[TBL] [Abstract][Full Text] [Related]
7. [The function of the peripheral adrenergic link under the action of neuroleptics in immobilization stress].
Khaĭsman EB; Arefolov VA; Malikova LA; Raevskiĭ KS
Farmakol Toksikol; 1991; 54(4):18-21. PubMed ID: 1686256
[TBL] [Abstract][Full Text] [Related]
8. Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
Kalkavoura CS; Michopoulos I; Arvanitakis P; Theodoropoulou P; Dimopoulou K; Tzebelikos E; Lykouras L
Exp Clin Psychopharmacol; 2013 Aug; 21(4):332-41. PubMed ID: 23834553
[TBL] [Abstract][Full Text] [Related]
9. Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.
Liang Y; Su YA; Zhao ZG; Gao N; Huang JZ; Tang MQ; Li KQ; Yang FD; Yu X; Si TM
J Clin Psychopharmacol; 2015 Oct; 35(5):583-6. PubMed ID: 26270200
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
[TBL] [Abstract][Full Text] [Related]
12. Amisulpride: a review of its efficacy in schizophrenia.
Möller HJ
Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
[TBL] [Abstract][Full Text] [Related]
13. [Features of the development and clinical picture of hysterical neurosis and hysterical neurotic personality development].
Shashkova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1668-71. PubMed ID: 3811731
[TBL] [Abstract][Full Text] [Related]
14. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of sulpiride with chlordiazepoxide in neurosis.
Toru M; Moriya H; Yamamoto K; Shimazono Y
Folia Psychiatr Neurol Jpn; 1976; 30(2):153-64. PubMed ID: 786820
[TBL] [Abstract][Full Text] [Related]
16. Sulpiride: evaluation of antipsychotic activity in schizophrenic patients.
Mielke DH; Gallant DM; Roniger JJ; Kessler C; Kessler LR
Dis Nerv Syst; 1977 Jul; 38(7):569-71. PubMed ID: 326504
[TBL] [Abstract][Full Text] [Related]
17. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
[TBL] [Abstract][Full Text] [Related]
18. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
19. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
[TBL] [Abstract][Full Text] [Related]
20. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Fric M; Laux G
Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
